ImmuCell Corp. (ICCC)
6.44
+0.09
(+1.42%)
USD |
NASDAQ |
Apr 02, 16:00
6.30
-0.14
(-2.17%)
After-Hours: 20:00
ImmuCell EPS Diluted (Quarterly) : -0.315 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cumberland Pharmaceuticals, Inc. | -0.0944 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.849M |
| Revenue (Quarterly) | 7.626M |
| Total Expenses (Quarterly) | 10.48M |
| Enterprise Value | 67.65M |
| Gross Profit Margin (Quarterly) | 38.16% |
| Profit Margin (Quarterly) | -37.36% |
| Earnings Yield | -1.78% |
| Operating Earnings Yield | 2.86% |
| Normalized Earnings Yield | 1.451 |